STERIS plc (NYSE:STE) Shares Sold by Mitsubishi UFJ Trust & Banking Corp

Mitsubishi UFJ Trust & Banking Corp lowered its stake in STERIS plc (NYSE:STE) by 2.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 45,617 shares of the medical equipment provider’s stock after selling 1,322 shares during the period. Mitsubishi UFJ Trust & Banking Corp’s holdings in STERIS were worth $9,377,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of STE. Avalon Trust Co acquired a new position in STERIS in the 4th quarter valued at $30,000. Human Investing LLC purchased a new stake in shares of STERIS in the fourth quarter valued at about $31,000. Anfield Capital Management LLC increased its stake in shares of STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 91 shares during the period. Central Pacific Bank Trust Division raised its holdings in STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC lifted its position in STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 137 shares during the period. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on STE shares. Piper Sandler boosted their target price on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a report on Thursday, February 6th. Finally, Stephens reiterated an “overweight” rating and issued a $240.00 price objective on shares of STERIS in a research report on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, STERIS currently has a consensus rating of “Moderate Buy” and an average price target of $258.75.

STERIS Price Performance

Shares of NYSE:STE opened at $222.99 on Friday. The firm has a market capitalization of $21.91 billion, a price-to-earnings ratio of 47.34 and a beta of 0.92. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The business’s 50 day simple moving average is $222.51 and its 200-day simple moving average is $221.30. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24.

STERIS (NYSE:STE) last posted its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, equities analysts forecast that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were paid a $0.57 dividend. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.02%. STERIS’s payout ratio is 48.41%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.